Literature DB >> 2909141

Therapeutic efficacy and safety of oral propafenone for atrial fibrillation.

J G Porterfield1, L M Porterfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2909141     DOI： 10.1016/0002-9149(89)91091-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  13 in total

1.  Effects of propafenone on K currents in human atrial myocytes.

Authors:  A Seki; N Hagiwara; H Kasanuki
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

2.  The drug treatment of atrial fibrillation.

Authors:  K S Channer
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

Review 3.  The pharmacologic treatment of atrial fibrillation.

Authors:  R Bolognesi
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

4.  Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound.

Authors:  J Ge; F Chirillo; J Schwedtmann; G Görge; M Haude; D Baumgart; V Shah; C von Birgelen; S Sack; H Boudoulas; R Erbel
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

5.  Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study.

Authors:  G E Kochiadakis; N E Igoumenidis; M E Marketou; M D Kaleboubas; E N Simantirakis; P E Vardas
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

Review 6.  Pharmacological cardioversion of atrial fibrillation: current management and treatment options.

Authors:  Giuseppe Boriani; Igor Diemberger; Mauro Biffi; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Is there a future for antiarrhythmic drug therapy?

Authors:  P G Guerra; M Talajic; D Roy; M Dubuc; B Thibault; S Nattel
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

Review 8.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

9.  Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group.

Authors:  H J Crijns; A T Gosselink; K I Lie
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

10.  Coronary atherosclerotic lesions in human immunodeficiency virus-infected patients: a histopathologic study.

Authors:  Robert G Micheletti; Gregory A Fishbein; Michael C Fishbein; Elyse J Singer; Robert E Weiss; Robin A Jeffries; Judith S Currier
Journal:  Cardiovasc Pathol       Date:  2008-03-04       Impact factor: 2.185
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.